Brain volume loss and physical and cognitive impairment in naive multiple sclerosis patients treated with fingolimod: prospective cohort study in Buenos Aires, Argentina.

Published in: Arquivos de neuro-psiquiatria (2022)

year in naïve MS patients was independently associated with a significant risk of CI and EDSS progression.

Keyphrases